GBIO
Generation Bio Co
NASDAQ: GBIO · HEALTHCARE · BIOTECHNOLOGY
$5.34
+0.00% today
Updated 2026-02-09
Market cap
$35.98M
P/E ratio
—
P/S ratio
2.36x
EPS (TTM)
$-9.37
Dividend yield
—
52W range
$3 – $7
Volume
0.1M
Generation Bio Co (GBIO) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | $36000.00 | $0.00 | $0.00 | $0.00 | $880000.00 | $5.90M | $19.89M |
| Revenue growth (YoY) | — | -100.0% | — | — | — | +570.9% | +236.9% |
| Cost of revenue | — | $1.86M | $3.43M | $4.53M | $5.13M | $5.26M | $4.93M |
| Gross profit | $36000.00 | $-1.86M | $-3.43M | $-4.53M | $-5.13M | $5.90M | $19.89M |
| Gross margin | 100.0% | — | — | — | -583.0% | 100.0% | 100.0% |
| R&D | $28.15M | $50.13M | $58.53M | $85.25M | $96.72M | $93.62M | $61.30M |
| SG&A | $9.18M | $12.17M | $22.58M | $33.85M | $44.46M | $50.85M | $37.78M |
| Operating income | $-37.29M | $-62.30M | $-81.11M | $-119.10M | $-141.18M | $-138.56M | $-142.39M |
| Operating margin | -103594.4% | — | — | — | -16043.4% | -2346.9% | -715.8% |
| EBITDA | $-36.95M | $-60.44M | $-77.68M | $-114.57M | $-136.05M | $-133.30M | $-74.26M |
| EBITDA margin | -102630.6% | — | — | — | -15460.5% | -2257.8% | -373.3% |
| EBIT | $-37.29M | $-62.30M | $-81.11M | $-119.10M | $-141.18M | $-138.56M | $-79.19M |
| Interest expense | $0.00 | $0.00 | $591000.00 | $50000.00 | $4.54M | $11.95M | — |
| Income tax | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-35.80M | $-60.33M | $-76.50M | $-114.67M | $-132.10M | $-126.61M | $-131.67M |
| Net income growth (YoY) | — | -68.5% | -26.8% | -49.9% | -15.2% | +4.2% | -4.0% |
| Profit margin | -99452.8% | — | — | — | -15010.9% | -2144.5% | -661.9% |